Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
GSK PLC GLAXF
News
GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial
GSK's Rectal Cancer Drug Jemperli Accepted for Priority Review by FDA
GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline — Update
GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline
GSK Gets U.S. Approval for Jideytro for Certain Lung Cancers
GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment
GSK Stops Development of Drug Candidate for Chronic Cough
Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK — Update
GSK, Spero Therapeutics Gain U.S. Approval for Utebzi
Nuvalent Shares Leap Premarket on Takeover by GSK
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push — Update
Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
GSK Says Hepatitis B Drug Cured One Fifth of Patients in Late-Stage Trials — Update
GSK Says Hepatitis B Drug Candidate Cured Some Patients in Late-Stage Trials
GSK Partners With SBP to Speed Up China Rollout of Hepatitis Drug
GSK Earnings Boosted by Higher Specialty Medicine Sales
GSK's RSV Vaccine Receives Expanded FDA Approval
GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million
United States